Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ActivBiotics raises $26.4 million

Infectious disease company ActivBiotics (Lexington, Mass.) raised $26.4 million in the

Read the full 117 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE